Alvorlig neutropeni (grad 4 - neutrofiltal < 0, 5 x 109/ l) sås hos 32% af patienterne i 13% af behandlingsperioderne.
Severe neutropenia (Grade 4 - neutrophil count < 0.5 x 109/ l) occurred in 32% of patients in 13% of courses.